Results 241 to 250 of about 325,683 (268)

Tumor‐Specific Delivery of CD28 siRNA via Lyso‐PC C‐16 Modified Lipid Nanoparticles Overcomes Anti‐PD‐1 Resistance by Remodeling Tumor Microenvironment

open access: yesAdvanced Science, EarlyView.
This study develops 16:0 LPC‐modified lipid nanoparticles (LPC‐LNPs) with cancer cell specificity by exploiting altered tumor lipid metabolism. LPC‐LNPs encapsulating Cd28 small interfering RNA (LPC‐LNP‐Cd28) knock down cancer cell CD28 without affecting T cells, inflame the tumor microenvironment, and overcome anti‐PD‐1 resistance.
Yangyang Chai   +12 more
wiley   +1 more source

Coronavirus M Protein Hijacks Toll-Interacting Protein (TOLLIP) to Suppress NF-κB Signaling and Promote Immune Evasion. [PDF]

open access: yesMedComm (2020)
Zhang Y   +10 more
europepmc   +1 more source

mRNA Delivery by Lipoamino Fatty Acid-Peptide Polyplexes in Different Lung Cell Models and Lungs. [PDF]

open access: yesPolymers (Basel)
Thalmayr S   +8 more
europepmc   +1 more source

Mutational analyses of an instability domain reveal its conserved role in the regulation of class-B ARF levels in <i>Arabidopsis</i>. [PDF]

open access: yesProc Natl Acad Sci U S A
Ban Z   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Beyond luciferase-luciferin system: Modification, improved imaging and biomedical application

Coordination Chemistry Reviews, 2023
Xiaorui Shi, Chu Tang, Fu Wang
exaly  

Supramolecular Control over Split‐Luciferase Complementation

Angewandte Chemie - International Edition, 2016
Lech-Gustav Milroy   +2 more
exaly  

Home - About - Disclaimer - Privacy